Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%. Equities research analysts expect that Bio-Rad Laboratories, Inc. will post 10.81 EPS for the ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Bio-Rad Laboratories, Inc, a leading provider of life science research and clinical diagnostics solutions, has unveiled the ...

Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Bio-Rad Laboratories in a research ...

Explore how BIO's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Life ...

Bio-Rad Laboratories is navigating market challenges with a focus on operational efficiency, strategic acquisitions, and innovation. While the company projects modest revenue growth and gross ...

HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics ...

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...